Cadila Healthcare says can ramp up HCQ capacity, vaccine to enter human testing in Q2FY20

The company#39;s MD Sharvil Patel said Cadila doesn#39;t depend on imports for the drug, implying that it makes key starting material and intermediates that are typically imported from China for most other drugs

from Moneycontrol Business News https://ift.tt/2x9StcN